indomethacin has been researched along with Proteinuria in 101 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Proteinuria: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Because the cardiovascular system (CVS) side-effects of cyclooxygenase-2 (COX-2) selective inhibitors have recently been questioned, we aimed to compare the renal and haemodynamic effects of cyclooxygenase selective (celecoxib and rofecoxib) and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) (indomethacin) in patients with renal amyloidosis secondary to rheumatological diseases who required anti-inflammatory agents and are taking maximum tolerable dose of angiotensin-converting enzyme inhibitors." | 9.12 | Effect of indomethacin and selective cyclooxygenase-2 inhibitors on proteinuria and renal function in patients with AA type renal amyloidosis. ( Akdag, I; Demircan, C; Dilek, K; Ersoy, A; Gullulu, M; Kahvecioglu, S; Yurtkuran, M, 2006) |
| "Administration of prednisolone causes an abrupt rise in proteinuria in patients with a nephrotic syndrome." | 9.09 | Acute haemodynamic and proteinuric effects of prednisolone in patients with a nephrotic syndrome. ( Koene, RA; Reichert, LJ; Wetzels, JF, 1999) |
| "The effects of indomethacin on urinary protein excretion, levels of serum albumin and renal function were studied prospectively in six patients with systemic lupus erythematosus (SLE) and refractory nephrotic syndrome due to lupus nephritis." | 9.07 | Refractory nephrotic syndrome in lupus nephritis: favorable response to indomethacin therapy. ( Cuellar, ML; Espinoza, LR; Jara, LJ; Martinez-Osuna, P; Seleznick, M; Silveira, LH, 1993) |
| " The cyclooxygenase inhibitor indomethacin reduces proteinuria in patients with focal segmental glomerulosclerosis (FSGS) or other glomerular diseases." | 7.71 | Indomethacin protects permeability barrier from focal segmental glomerulosclerosis serum. ( McCarthy, ET; Sharma, M, 2002) |
| "Two infants with biopsy-proven microcystic Finnish congenital nephrotic syndrome (onset at birth) were treated with a combination of captopril and indomethacin for 2 1/2 and 2 years, respectively; they had a marked reduction of urinary protein excretion without further need for albumin infusions." | 7.69 | Successful treatment of Finnish congenital nephrotic syndrome with captopril and indomethacin. ( Bernheim, J; Korzets, Z; Pomeranz, A; Wolach, B, 1995) |
| "Immediate and longer-term (five-day) effects of indomethacin on proteinuria and renal function were examined in a group of nephrotic subjects with glomerular filtration rates (GFR) that ranged from near normal to moderately impaired." | 7.67 | Reduction of proteinuria by indomethacin in patients with nephrotic syndrome. ( Alavi, N; Bentzel, CJ; Lianos, EA; Mookerjee, BK; Venuto, RC, 1986) |
| "Indomethacin has been used to lower proteinuria in human glomerular diseases with controversial results." | 7.67 | Indomethacin reduces proteinuria in passive Heymann nephritis in rats. ( Benigni, A; Bertani, T; Remuzzi, G; Ronco, P; Verroust, P; Zoja, C, 1987) |
| "The effect of treatment with indomethacin on the ability of dimethyl sulfoxide (DMSO) to reduce proteinuria in rats with passive Heymann's nephritis (PHN) was studied." | 7.67 | Interactions of dimethyl sulfoxide and nonsteroidal anti-inflammatory agents in passive Heymann's nephritis. ( Fong, JS; Goodyer, PR; Kaplan, BS; Lotan, D; Mills, M; Milner, LS, 1986) |
| "In 25 patients with nephrotic syndromes of different origin, indomethacin caused an immediate decrease in glomerular filtration rate (GFR) and urinary protein excretion." | 7.66 | Treatment of the nephrotic syndrome with indomethacin. ( Arisz, L; Brentjens, JR; Donker, AJ; van der Hem, GK, 1978) |
| "The effects of long-term indomethacin therapy were studied in rats with chronic nephrosis induced by puromycin of aminonucleoside (PAN)." | 7.66 | Adverse effect of indomethacin in experimental chronic nephrosis. ( Gros, F; Gubler, MC; Kleinknecht, C; Laouari, D, 1983) |
| "1 The effects of aspirin, prednisolone, and indomethacin on nephrotoxic serum nephritis in rats was studied." | 7.66 | Effects of aspirin, prednisolone and indomethacin on nephrotoxic serum nephritis in the rat. ( Kurokawa, H; Sakamoto, K, 1982) |
| "Ten patients with idiopathic minimal lesion nephrotic syndrome were treated with indomethacin." | 7.66 | Indomethacin in the treatment of idiopathic minimal lesion nephrotic syndrome. ( Fennell, RS; Garin, EH; Richard, GA; Williams, RL, 1978) |
| "Indomethacin given to adults with glomerulonephritis usually reduces their urinary excretion of protein and fibrinogen/fibrin-related (F." | 7.65 | Indomethacin and platelet aggregation in chronic glomerulonephritis: existence of non-responders. ( De Gaetano, G; Donati, MB; Dotremont, G; Michielsen, P; Vermylen, J, 1974) |
| "33 cases of chronic glomerulonephritis who responded unsatisfactorily to treatment with indomethacin alone were treated in addition with a low dose of cyclophosphamide." | 7.65 | Treatment of chronic glomerulonephritis with a combination of indomethacin and cyclophosphamide. ( Michielsen, P; Roels, L; Vanrenterghem, Y; Verberckmoes, R, 1975) |
| "The effect of indomethacin on protein excretion and on the synthesis of glomerular basement membrane (GBM) was studied during various stages of nephrotoxic nephritis (NTN) in the rat." | 7.65 | Effect of indomethacin on the synthesis of glomerular basement membrane and on proteinuria in rats with nephrotoxic nephritis. ( Blok, AP; Daha, MR; de Graeff, J; van Es, LA, 1977) |
| "Treatment with indomethacin, aspirin, or prednisone has been shown to reduce urinary fibrin/fibrinogen degradation products (F." | 6.64 | Modification by drugs of urinary fibrin/fibrinogen degradation products in glomerulonephritis. ( Cash, JD; Clarkson, AR; MacDonald, MK; Robson, JS, 1972) |
| "Indomethacin and saralasin were used to study the possible roles of prostaglandins and angiotensin II (A-II) in the adaptation to NSN." | 5.27 | Role of prostaglandins and angiotensin II in experimental glomerulonephritis. ( Glassock, RJ; Kaizu, K; Marsh, D; Zipser, R, 1985) |
| "Because the cardiovascular system (CVS) side-effects of cyclooxygenase-2 (COX-2) selective inhibitors have recently been questioned, we aimed to compare the renal and haemodynamic effects of cyclooxygenase selective (celecoxib and rofecoxib) and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) (indomethacin) in patients with renal amyloidosis secondary to rheumatological diseases who required anti-inflammatory agents and are taking maximum tolerable dose of angiotensin-converting enzyme inhibitors." | 5.12 | Effect of indomethacin and selective cyclooxygenase-2 inhibitors on proteinuria and renal function in patients with AA type renal amyloidosis. ( Akdag, I; Demircan, C; Dilek, K; Ersoy, A; Gullulu, M; Kahvecioglu, S; Yurtkuran, M, 2006) |
| "The effect of maximum tolerated ACEi doses (ramipril 15 mg/day, range 5 to 20) alone or combined with indomethacin (75 mg x 2/day) on urinary protein excretion (UPE) and glomerular barrier size-selective function was evaluated in 19 patients with chronic non-diabetic nephropathies and persistent proteinuria." | 5.10 | Effect of high dose ramipril with or without indomethacin on glomerular selectivity. ( Lepre, MS; Pisoni, R; Remuzzi, A; Remuzzi, G; Ruggenenti, P; Sangalli, F, 2002) |
| "Administration of prednisolone causes an abrupt rise in proteinuria in patients with a nephrotic syndrome." | 5.09 | Acute haemodynamic and proteinuric effects of prednisolone in patients with a nephrotic syndrome. ( Koene, RA; Reichert, LJ; Wetzels, JF, 1999) |
| "The effects of indomethacin on urinary protein excretion, levels of serum albumin and renal function were studied prospectively in six patients with systemic lupus erythematosus (SLE) and refractory nephrotic syndrome due to lupus nephritis." | 5.07 | Refractory nephrotic syndrome in lupus nephritis: favorable response to indomethacin therapy. ( Cuellar, ML; Espinoza, LR; Jara, LJ; Martinez-Osuna, P; Seleznick, M; Silveira, LH, 1993) |
| " Both the angiotensin-converting enzyme inhibitor, lisinopril, and the non-steroidal anti-inflammatory drug, indomethacin, lower urinary protein excretion in renal disease and improve the selectivity of the residual proteinuria." | 5.07 | Additive antiproteinuric effect of angiotensin-converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: a clue to the mechanism of action. ( de Jong, PE; de Zeeuw, D; Heeg, JE, 1991) |
| "We studied the efficacy of the ACE inhibitor lisinopril in treating overt proteinuria in comparison with the NSAID indomethacin, and evaluated some of the conditions that could influence this antiproteinuric effect." | 5.06 | Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. ( de Jong, PE; de Zeeuw, D; Heeg, JE; van der Hem, GK, 1989) |
| "In a double-blind crossover study in 10 salt-depleted nephrotic patients the reduction of proteinuria was significantly larger during indomethacin 50 mg three times daily than during naproxen 250 or 500 mg three times daily (72 vs." | 5.05 | Antiproteinuric effect of naproxen and indomethacin. A double-blind crossover study. ( de Jong, PE; de Zeeuw, D; Donker, AJ; van der Hem, GK; Vriesendorp, R, 1985) |
| " Angiotensin-converting enzyme (ACE) inhibitors were used to reduce proteinuria in all infants, and one was also treated with indomethacin." | 3.77 | Nephrotic syndrome in infancy can spontaneously resolve. ( Clothier, J; Kim, JJ; Milford, DV; Moghal, N; Sebire, NJ; Trompeter, RS, 2011) |
| " The cyclooxygenase inhibitor indomethacin reduces proteinuria in patients with focal segmental glomerulosclerosis (FSGS) or other glomerular diseases." | 3.71 | Indomethacin protects permeability barrier from focal segmental glomerulosclerosis serum. ( McCarthy, ET; Sharma, M, 2002) |
| " Treatment of -/- pups with indomethacin from day 1 prevented growth retardation and 10% treated for 3 weeks survived, although as adults they exhibited severe polyuria (10 ml/day), extreme hydronephrosis, low plasma potassium, high blood pH, hypercalciuria, and proteinuria." | 3.70 | Uncompensated polyuria in a mouse model of Bartter's syndrome. ( Chernavvsky, DR; Gitelman, HJ; Gomez, RA; Igarashi, P; Smithies, O; Takahashi, N, 2000) |
| "Two infants with biopsy-proven microcystic Finnish congenital nephrotic syndrome (onset at birth) were treated with a combination of captopril and indomethacin for 2 1/2 and 2 years, respectively; they had a marked reduction of urinary protein excretion without further need for albumin infusions." | 3.69 | Successful treatment of Finnish congenital nephrotic syndrome with captopril and indomethacin. ( Bernheim, J; Korzets, Z; Pomeranz, A; Wolach, B, 1995) |
| "In this study we investigated whether the increase in proteinuria induced by an oral protein load may be prevented by the angiotensin-converting enzyme inhibitor (ACEI) captopril in patients with nephrotic syndrome, and whether the effects of captopril on renal haemodynamics and/or glomerular selectivity are comparable to those obtained with the nonsteroidal anti-inflammatory drug (NSAID) indomethacin and the calcium-channel blocker (CaCB) nifedipine." | 3.69 | Renal effects of captopril, indomethacin and nifedipine in nephrotic patients after an oral protein load. ( Allegri, L; Borghetti, A; Buzio, C; Garini, G; Mazzi, A; Mutti, A; Savazzi, G, 1996) |
| "Nonsteroidal anti-inflammatory drugs, especially indomethacin, have variable effects on proteinuria when used alone, but can dramatically reduce proteinuria if combined with diuretics and sodium restriction." | 3.68 | Prostaglandins, angiotension II, and proteinuria. ( Dunn, MJ, 1990) |
| "Indomethacin has been used to lower proteinuria in human glomerular diseases with controversial results." | 3.67 | Indomethacin reduces proteinuria in passive Heymann nephritis in rats. ( Benigni, A; Bertani, T; Remuzzi, G; Ronco, P; Verroust, P; Zoja, C, 1987) |
| "The effect of treatment with indomethacin on the ability of dimethyl sulfoxide (DMSO) to reduce proteinuria in rats with passive Heymann's nephritis (PHN) was studied." | 3.67 | Interactions of dimethyl sulfoxide and nonsteroidal anti-inflammatory agents in passive Heymann's nephritis. ( Fong, JS; Goodyer, PR; Kaplan, BS; Lotan, D; Mills, M; Milner, LS, 1986) |
| "To elucidate the mechanisms by which indomethacin lowers proteinuria, we studied 20 patients with the nephrotic syndrome." | 3.67 | Mechanism of the antiproteinuric effect of indomethacin in nephrotic humans. ( Black, V; Golbetz, H; Myers, BD; Shemesh, O, 1989) |
| "Immediate and longer-term (five-day) effects of indomethacin on proteinuria and renal function were examined in a group of nephrotic subjects with glomerular filtration rates (GFR) that ranged from near normal to moderately impaired." | 3.67 | Reduction of proteinuria by indomethacin in patients with nephrotic syndrome. ( Alavi, N; Bentzel, CJ; Lianos, EA; Mookerjee, BK; Venuto, RC, 1986) |
| " Indomethacin, diclofenac-sodium and flurbiprofen decreased proteinuria, glomerular filtration rate, plasma renin activity and renal prostaglandin E2 excretion by 59%, 19%, 55% and 68% respectively." | 3.67 | Reduction of urinary protein and prostaglandin E2 excretion in the nephrotic syndrome by non-steroidal anti-inflammatory drugs. ( de Jong, PE; de Zeeuw, D; Donker, AJ; Pratt, JJ; van der Hem, GK; Vriesendorp, R, 1986) |
| "The effects of long-term indomethacin therapy were studied in rats with chronic nephrosis induced by puromycin of aminonucleoside (PAN)." | 3.66 | Adverse effect of indomethacin in experimental chronic nephrosis. ( Gros, F; Gubler, MC; Kleinknecht, C; Laouari, D, 1983) |
| "1 The effects of aspirin, prednisolone, and indomethacin on nephrotoxic serum nephritis in rats was studied." | 3.66 | Effects of aspirin, prednisolone and indomethacin on nephrotoxic serum nephritis in the rat. ( Kurokawa, H; Sakamoto, K, 1982) |
| "Ten patients with idiopathic minimal lesion nephrotic syndrome were treated with indomethacin." | 3.66 | Indomethacin in the treatment of idiopathic minimal lesion nephrotic syndrome. ( Fennell, RS; Garin, EH; Richard, GA; Williams, RL, 1978) |
| "In 25 patients with nephrotic syndromes of different origin, indomethacin caused an immediate decrease in glomerular filtration rate (GFR) and urinary protein excretion." | 3.66 | Treatment of the nephrotic syndrome with indomethacin. ( Arisz, L; Brentjens, JR; Donker, AJ; van der Hem, GK, 1978) |
| "The effect of indomethacin on protein excretion and on the synthesis of glomerular basement membrane (GBM) was studied during various stages of nephrotoxic nephritis (NTN) in the rat." | 3.65 | Effect of indomethacin on the synthesis of glomerular basement membrane and on proteinuria in rats with nephrotoxic nephritis. ( Blok, AP; Daha, MR; de Graeff, J; van Es, LA, 1977) |
| "33 cases of chronic glomerulonephritis who responded unsatisfactorily to treatment with indomethacin alone were treated in addition with a low dose of cyclophosphamide." | 3.65 | Treatment of chronic glomerulonephritis with a combination of indomethacin and cyclophosphamide. ( Michielsen, P; Roels, L; Vanrenterghem, Y; Verberckmoes, R, 1975) |
| "Indomethacin given to adults with glomerulonephritis usually reduces their urinary excretion of protein and fibrinogen/fibrin-related (F." | 3.65 | Indomethacin and platelet aggregation in chronic glomerulonephritis: existence of non-responders. ( De Gaetano, G; Donati, MB; Dotremont, G; Michielsen, P; Vermylen, J, 1974) |
| "When indomethacin was added to enalapril treatment, a further significant reduction in urinary proteins and fractional albumin clearance was observed." | 2.69 | The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin. ( Azzollini, N; Mister, M; Perico, N; Remuzzi, A; Remuzzi, G; Ruggenenti, P; Sangalli, F, 1998) |
| "Exercise proteinuria was significantly increased by indomethacin but not by sulindac." | 2.66 | Renal prostaglandin E2 and F2 alpha synthesis during exercise: effects of indomethacin and sulindac. ( Dodelson, R; Guidotti, SM; Harnett, CA; Zambraski, EJ, 1986) |
| "Treatment with indomethacin, aspirin, or prednisone has been shown to reduce urinary fibrin/fibrinogen degradation products (F." | 2.64 | Modification by drugs of urinary fibrin/fibrinogen degradation products in glomerulonephritis. ( Cash, JD; Clarkson, AR; MacDonald, MK; Robson, JS, 1972) |
| "Vitamin D deficiency is common in chronic kidney disease (CKD)." | 1.38 | Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease. ( de Borst, MH; de Cuba, MM; Doorenbos, CR; Gans, RO; Kema, IP; Navis, G; van den Born, J; Vogt, L, 2012) |
| "Reduction of proteinuria is a prerequisite for successful long-term renoprotection." | 1.31 | Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy. ( Andersen, S; Bos, H; De Jong, PE; De Zeeuw, D; Navis, G; Parving, HH; Rossing, P, 2000) |
| "Pretreatment with indomethacin partly inhibited the increments in clearances of macromolecules." | 1.27 | Intravenously administered frusemide increases glomerular permeability. ( Ala-Houhala, I; Pasternack, A; Vapaatalo, H, 1987) |
| "Indomethacin and saralasin were used to study the possible roles of prostaglandins and angiotensin II (A-II) in the adaptation to NSN." | 1.27 | Role of prostaglandins and angiotensin II in experimental glomerulonephritis. ( Glassock, RJ; Kaizu, K; Marsh, D; Zipser, R, 1985) |
| "Rats treated with indomethacin showed a marked decrease of proteinuria (tested by the 3% sulfosalicylic aicd method) and a clear ultrastructural picture of hyperplasia and hypertrophy of podocytes." | 1.26 | Indomethacin and lysine acetylsalicylate in rats with autologous nephrotoxic serum nephritis. Biochemical and morphological studies. ( Cioffi, A; Conte, F; Di Belgiojoso, GB; Donati, MB; Saruggia, M; Sessa, A, 1978) |
| "70 cases of focal glomerulosclerosis (FGS) followed for periods ranging from 1 to 24 years are reported." | 1.26 | Focal glomerulosclerosis: natural history and treatment. A report of 70 cases. ( Alphonse, JC; Beaufils, H; Guedon, J; Legrain, M, 1978) |
| "A 61 year old man experienced oliguric acute renal failure during therapy with indomethacin." | 1.26 | Indomethacin-associated acute renal failure. ( Dodelson, R; Eisinger, RP; Gary, NE, 1980) |
| "Indomethacin in vitro has no effect." | 1.26 | Effect of indomethacin on lymphocyte response to mitogens in puromycin aminonucleoside nephrosis in the rat. ( Barratt, TM; Garin, EH, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 72 (71.29) | 18.7374 |
| 1990's | 18 (17.82) | 18.2507 |
| 2000's | 8 (7.92) | 29.6817 |
| 2010's | 3 (2.97) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vogt, L | 3 |
| de Zeeuw, D | 8 |
| Woittiez, AJ | 1 |
| Navis, G | 4 |
| Kim, JJ | 1 |
| Clothier, J | 1 |
| Sebire, NJ | 1 |
| Milford, DV | 1 |
| Moghal, N | 1 |
| Trompeter, RS | 1 |
| Doorenbos, CR | 1 |
| de Cuba, MM | 1 |
| Kema, IP | 1 |
| van den Born, J | 1 |
| Gans, RO | 1 |
| de Borst, MH | 2 |
| Nauta, FL | 1 |
| Laverman, GD | 1 |
| Gansevoort, RT | 1 |
| Pisoni, R | 1 |
| Ruggenenti, P | 2 |
| Sangalli, F | 2 |
| Lepre, MS | 1 |
| Remuzzi, A | 2 |
| Remuzzi, G | 4 |
| Takano, T | 1 |
| Cybulsky, AV | 2 |
| Cupples, WA | 1 |
| Ajikobi, DO | 1 |
| Papillon, J | 1 |
| Aoudjit, L | 1 |
| Hattori, M | 1 |
| Kahvecioglu, S | 1 |
| Dilek, K | 1 |
| Akdag, I | 1 |
| Gullulu, M | 1 |
| Demircan, C | 1 |
| Ersoy, A | 1 |
| Yurtkuran, M | 1 |
| Michielsen, P | 9 |
| Lambert, PP | 1 |
| Garin, EH | 3 |
| Richard, GA | 2 |
| Varenterghem, Y | 1 |
| Jacob, CK | 1 |
| Date, A | 1 |
| Kirubakaran, MG | 1 |
| Shastry, JC | 1 |
| Johny, KV | 1 |
| Kleinknecht, C | 1 |
| Laouari, D | 1 |
| Gubler, MC | 1 |
| Gros, F | 1 |
| Tomilina, NA | 1 |
| Biriukova, LS | 1 |
| Suzuki, Y | 1 |
| Ito, M | 1 |
| Saito, N | 1 |
| Nagamatsu, T | 1 |
| Iwaoka, T | 1 |
| Umeda, T | 1 |
| Nakayama, M | 1 |
| Shimada, T | 1 |
| Fujii, Y | 1 |
| Miura, F | 1 |
| Sato, T | 1 |
| Kurokawa, H | 1 |
| Sakamoto, K | 1 |
| Androsova, SO | 1 |
| Kutyrina, IM | 1 |
| Barratt, TM | 1 |
| Sato, K | 1 |
| Murata, T | 1 |
| Maeta, T | 1 |
| Matsumoto, J | 1 |
| Kaneda, H | 1 |
| Haruyama, T | 1 |
| Wakasa, H | 1 |
| Hara, M | 1 |
| Kanno, M | 1 |
| Nagaoka, A | 1 |
| Kakihana, M | 1 |
| Iwatsuka, H | 1 |
| Gary, NE | 1 |
| Dodelson, R | 2 |
| Eisinger, RP | 1 |
| Mertz, DP | 1 |
| Pomeranz, A | 1 |
| Wolach, B | 1 |
| Bernheim, J | 2 |
| Korzets, Z | 1 |
| Duda, SH | 1 |
| Raible, RT | 1 |
| Risler, T | 1 |
| Huppert, PE | 1 |
| Brambs, HJ | 1 |
| Gregor, M | 1 |
| Vanrenterghem, Y | 3 |
| Espinoza, LR | 1 |
| Jara, LJ | 1 |
| Martinez-Osuna, P | 1 |
| Silveira, LH | 1 |
| Cuellar, ML | 1 |
| Seleznick, M | 1 |
| Garini, G | 1 |
| Mazzi, A | 1 |
| Buzio, C | 1 |
| Mutti, A | 1 |
| Allegri, L | 1 |
| Savazzi, G | 1 |
| Borghetti, A | 1 |
| Hanson, B | 1 |
| D'Hondt, A | 1 |
| Depierreux, M | 1 |
| Lustman, F | 1 |
| Pollock, DM | 1 |
| Polakowski, JS | 1 |
| Wegner, CD | 1 |
| Opgenorth, TJ | 1 |
| Perico, N | 2 |
| Azzollini, N | 1 |
| Mister, M | 1 |
| Reichert, LJ | 1 |
| Koene, RA | 1 |
| Wetzels, JF | 1 |
| Takahashi, N | 1 |
| Chernavvsky, DR | 1 |
| Gomez, RA | 1 |
| Igarashi, P | 1 |
| Gitelman, HJ | 1 |
| Smithies, O | 1 |
| Bos, H | 1 |
| Andersen, S | 1 |
| Rossing, P | 1 |
| Parving, HH | 1 |
| De Jong, PE | 7 |
| McCarthy, ET | 1 |
| Sharma, M | 1 |
| Couser, WG | 1 |
| Stilmant, MM | 1 |
| Jermanovich, NB | 1 |
| Fünistück, R | 1 |
| Stein, G | 1 |
| Krohs, G | 1 |
| Sperschneider, H | 1 |
| Stelzner, A | 1 |
| Süsse, I | 1 |
| Waldmann, G | 1 |
| Kupor, LR | 1 |
| Lowance, DC | 1 |
| McPhaul, JJ | 1 |
| Lindeman, RD | 1 |
| Tamura, Y | 1 |
| Matsuda, Y | 1 |
| Yamada, K | 1 |
| Takagi, T | 1 |
| Nishikawa, T | 1 |
| Watanabe, M | 1 |
| Mikami, K | 1 |
| Moriya, H | 1 |
| Kumagai, A | 1 |
| Tiggeler, RG | 1 |
| Hulme, B | 1 |
| Wijdeveld, PG | 1 |
| Williams, RL | 1 |
| Fennell, RS | 1 |
| Beaufils, H | 1 |
| Alphonse, JC | 1 |
| Guedon, J | 1 |
| Legrain, M | 1 |
| Pap, I | 1 |
| Kemnitz, P | 1 |
| Willgeroth, Ch | 1 |
| Donker, AJ | 5 |
| Brentjens, JR | 3 |
| van der Hem, GK | 6 |
| Arisz, L | 3 |
| Sessa, A | 2 |
| Cioffi, A | 2 |
| Conte, F | 2 |
| Saruggia, M | 1 |
| Di Belgiojoso, GB | 1 |
| Donati, MB | 5 |
| Daha, MR | 1 |
| Blok, AP | 1 |
| de Graeff, J | 1 |
| van Es, LA | 1 |
| Meijer, S | 1 |
| Bernheim, JL | 1 |
| Pokroy, N | 1 |
| Myers, BD | 3 |
| Roels, L | 2 |
| Verberckmoes, R | 1 |
| Hamada, A | 1 |
| Giudicelli, CP | 1 |
| Lagrue, G | 3 |
| Masbernard, A | 2 |
| Hirbec, G | 2 |
| Boel, A | 1 |
| van Damme, B | 2 |
| Vermylen, J | 5 |
| O'Hagan, KP | 1 |
| Hora, DF | 1 |
| Zambraski, EJ | 3 |
| Mittleman, KD | 1 |
| Heeg, JE | 3 |
| Bergstein, JM | 1 |
| Esnault, VL | 1 |
| Potiron-Josse, M | 1 |
| Testa, A | 1 |
| Ginet, JD | 1 |
| Le Carrer, D | 1 |
| Guenel, J | 1 |
| Stelwagen, T | 1 |
| de Jong, RJ | 1 |
| Dunn, MJ | 1 |
| Fioretto, P | 1 |
| Trevisan, R | 1 |
| Valerio, A | 1 |
| Avogaro, A | 1 |
| Borsato, M | 1 |
| Doria, A | 1 |
| Semplicini, A | 1 |
| Sacerdoti, D | 1 |
| Jones, S | 1 |
| Bognetti, E | 1 |
| Damrau, J | 1 |
| Shemesh, O | 2 |
| Ross, JC | 1 |
| Deen, WM | 1 |
| Grant, GW | 1 |
| Golbetz, H | 1 |
| Black, V | 1 |
| Kirschenbaum, MA | 1 |
| Liebross, BA | 1 |
| Serros, ER | 1 |
| Kaplan, BS | 1 |
| Milner, LS | 1 |
| Lotan, D | 1 |
| Mills, M | 1 |
| Goodyer, PR | 1 |
| Fong, JS | 1 |
| Zoja, C | 1 |
| Benigni, A | 1 |
| Verroust, P | 1 |
| Ronco, P | 1 |
| Bertani, T | 2 |
| Lieberthal, W | 1 |
| Quigg, RJ | 1 |
| Rennke, HG | 1 |
| Salant, DJ | 1 |
| Delaini, F | 1 |
| Tagliaferri, M | 1 |
| Abbate, M | 1 |
| Cucchi, M | 1 |
| van Hooff, JP | 1 |
| Leunissen, KM | 1 |
| Havenith, MG | 1 |
| Bosman, FT | 1 |
| Alavi, N | 1 |
| Lianos, EA | 1 |
| Venuto, RC | 1 |
| Mookerjee, BK | 1 |
| Bentzel, CJ | 1 |
| Vriesendorp, R | 3 |
| Pratt, JJ | 1 |
| Guidotti, SM | 1 |
| Harnett, CA | 1 |
| Ala-Houhala, I | 1 |
| Vapaatalo, H | 1 |
| Pasternack, A | 1 |
| Kaizu, K | 1 |
| Marsh, D | 1 |
| Zipser, R | 1 |
| Glassock, RJ | 1 |
| Banerjee, S | 1 |
| Sharma, VK | 1 |
| Pareek, SK | 1 |
| Ratnu, KS | 1 |
| Zech, P | 1 |
| Richard, P | 1 |
| Blanc-Brunat, N | 1 |
| Labeeuw, M | 1 |
| Colon, S | 1 |
| Pozet, N | 1 |
| Dupont, E | 1 |
| Fries, D | 1 |
| Traeger, J | 1 |
| Horbach, J | 1 |
| van Liebergen, F | 1 |
| Mastboom, J | 1 |
| Wijdeveld, P | 1 |
| Giudicelli, C | 1 |
| Orlowski, T | 1 |
| Gradowska, L | 1 |
| Lao, M | 1 |
| Rancewicz, Z | 1 |
| Rowinska, D | 1 |
| Allaria, PM | 1 |
| D'Amico, G | 1 |
| Vihert, AM | 1 |
| Glezer, GA | 2 |
| Megrelishvili, RI | 2 |
| Ryff, IM | 1 |
| Dotremont, G | 4 |
| Suc, JM | 1 |
| Conte, J | 1 |
| De Gaetano, G | 3 |
| Campanacci, L | 1 |
| Gambari, P | 1 |
| Castellani, A | 1 |
| Huber, W | 1 |
| Vikhert, AM | 1 |
| Bykovskaia, KN | 1 |
| Clarkson, AR | 1 |
| MacDonald, MK | 1 |
| Cash, JD | 1 |
| Robson, JS | 1 |
| Varese, LA | 1 |
| Antoniola, P | 1 |
| Bariéty, J | 1 |
| Druet, P | 1 |
| Milliez, P | 1 |
| Pierron, H | 1 |
| Manassero, J | 1 |
| Vaillaud, JC | 1 |
| Paglia, R | 1 |
| Orsini, A | 1 |
| Murisasco, A | 1 |
| Picon, G | 1 |
| Hebreard, J | 1 |
| Sansot, M | 1 |
| Aubert, L | 1 |
| Taramasco, J | 1 |
| Mrtin, J | 1 |
| Manassero, L | 1 |
| Riccitelli, ML | 1 |
| Strauss, RG | 1 |
| Schubert, WK | 1 |
| McAdams, AJ | 1 |
| Brass, H | 1 |
3 reviews available for indomethacin and Proteinuria
| Article | Year |
|---|---|
[Congenital nephrotic syndrome].
Topics: Albumins; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Genes, Recessive; Hum | 2004 |
Prostaglandin inhibitors in the treatment of nephrotic syndrome.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Humans; Indomethacin; Neph | 1991 |
Effects of nonsteroidal anti-inflammatory drugs on proteinuria.
Topics: Anti-Inflammatory Agents; Hemodynamics; Humans; Indomethacin; Kidney; Nephrotic Syndrome; Proteinuri | 1986 |
13 trials available for indomethacin and Proteinuria
| Article | Year |
|---|---|
Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Bloo | 2009 |
Effect of high dose ramipril with or without indomethacin on glomerular selectivity.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Ste | 2002 |
Effect of indomethacin and selective cyclooxygenase-2 inhibitors on proteinuria and renal function in patients with AA type renal amyloidosis.
Topics: Adult; Amyloidosis; Cyclooxygenase 2 Inhibitors; Drug Therapy, Combination; Female; Humans; Indometh | 2006 |
Refractory nephrotic syndrome in lupus nephritis: favorable response to indomethacin therapy.
Topics: Adult; Creatinine; Female; Humans; Indomethacin; Kidney; Lupus Nephritis; Middle Aged; Nephrotic Syn | 1993 |
The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflam | 1998 |
Acute haemodynamic and proteinuric effects of prednisolone in patients with a nephrotic syndrome.
Topics: Adolescent; Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; beta 2-Microglobulin | 1999 |
Additive antiproteinuric effect of angiotensin-converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: a clue to the mechanism of action.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Drug Thera | 1991 |
Captopril but not acebutolol, prazosin or indomethacin decreases postexercise proteinuria.
Topics: Acebutolol; Adult; Albuminuria; Captopril; Exercise; Female; Hemodynamics; Humans; Indomethacin; Pra | 1991 |
Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diet, Sodium-Restricted; Enalapril; | 1989 |
Renal prostaglandin E2 and F2 alpha synthesis during exercise: effects of indomethacin and sulindac.
Topics: Adult; Clinical Trials as Topic; Dinoprost; Dinoprostone; Double-Blind Method; Female; Humans; Inden | 1986 |
Antiproteinuric effect of naproxen and indomethacin. A double-blind crossover study.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Glomerular Filtration Rate; Huma | 1985 |
Use of a new anti-inflammatory agent, bucloxic acid, in the treatment of chronic glomerular nephropathies.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Blood Urea Nitrogen; Chronic Disease; Clinical Trials a | 1974 |
Modification by drugs of urinary fibrin/fibrinogen degradation products in glomerulonephritis.
Topics: Adolescent; Adult; Aged; Aspirin; Child; Creatinine; Female; Fibrin; Fibrinogen; Glomerulonephritis; | 1972 |
85 other studies available for indomethacin and Proteinuria
| Article | Year |
|---|---|
Nephrotic syndrome in infancy can spontaneously resolve.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Stero | 2011 |
Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cyclooxygenase Inhibitors; Drug Therapy, Comb | 2012 |
Indomethacin reduces glomerular and tubular damage markers but not renal inflammation in chronic kidney disease patients: a post-hoc analysis.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Chemokine CCL2; Creatinine; Cross- | 2012 |
Inhibition of cyclooxygenases reduces complement-induced glomerular epithelial cell injury and proteinuria in passive Heymann nephritis.
Topics: Actins; Animals; Complement System Proteins; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 In | 2003 |
[Effects of corticosteroid and indomethacin treatment on proteinuria].
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Female; Glomerulonephritis; Humans; Indomethacin; Male; M | 1967 |
Prostaglandin synthesis inhibitors and primary antibody response in experimental nephrotic syndrome.
Topics: Animals; Antibody-Producing Cells; Aspirin; Hemolytic Plaque Technique; Indomethacin; Isoantibodies; | 1984 |
Proteinuria and nonsteroid anti-inflammatory drugs.
Topics: Anti-Inflammatory Agents; Capillary Permeability; Creatinine; Glomerular Filtration Rate; Glomerulon | 1983 |
Effect of indomethacin on the proteinuria of diabetic nephropathy.
Topics: Adult; Diabetic Nephropathies; Female; Follow-Up Studies; Humans; Indomethacin; Kidney; Male; Middle | 1984 |
Adverse effect of indomethacin in experimental chronic nephrosis.
Topics: Animals; Chronic Disease; Female; Indomethacin; Kidney; Nephrosis; Proteinuria; Puromycin Aminonucle | 1983 |
[Indomethacin in the treatment of glomerulonephritis].
Topics: Adolescent; Adult; Female; Glomerulonephritis; Humans; Indomethacin; Male; Middle Aged; Nephrosis, L | 1983 |
[Antinephritic effect of tiaramide on experimental nephritis in rats. (1). Effects on nephrotic-type and crescentic-type anti-GBM nephritis].
Topics: Animals; Anti-Inflammatory Agents; Basement Membrane; Benzothiazoles; Glomerulonephritis; Indomethac | 1984 |
A case of membranous nephropathy associated with thyroid antigens.
Topics: Antigens; Chemical and Drug Induced Liver Injury; Chronic Disease; Female; Humans; Hypothyroidism; I | 1982 |
Effects of aspirin, prednisolone and indomethacin on nephrotoxic serum nephritis in the rat.
Topics: Animals; Aspirin; Indomethacin; Kidney; Kidney Function Tests; Male; Nephritis; Prednisolone; Protei | 1982 |
[Indomethacin in the treatment of chronic glomerulonephritis].
Topics: Adolescent; Adult; Aged; Child; Chronic Disease; Drug Evaluation; Female; Glomerulonephritis; Humans | 1982 |
Effect of indomethacin on lymphocyte response to mitogens in puromycin aminonucleoside nephrosis in the rat.
Topics: Animals; Indomethacin; Lymphocyte Activation; Male; Nephrotic Syndrome; Proteinuria; Puromycin Amino | 1982 |
[A case report of Bartter's syndrome with persistent microhematuria (author's transl)].
Topics: Adult; Bartter Syndrome; Female; Hematuria; Humans; Hyperaldosteronism; Indomethacin; Proteinuria | 1981 |
Effects of prostaglandin inhibitors on the onset of proteinuria and stroke in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Carbazoles; Cerebrovascular Disorders; Hypertension; Indomethacin; Prostagl | 1981 |
Indomethacin-associated acute renal failure.
Topics: Acute Kidney Injury; Humans; Hypertension; Indomethacin; Kidney Glomerulus; Male; Middle Aged; Prote | 1980 |
[Gout as a joint disease and as a generalized disease. Incidence, diagnosis and therapy].
Topics: Allopurinol; Colchicine; Diabetes Complications; Gout; Humans; Hypertension; Indomethacin; Kidney Di | 1980 |
Successful treatment of Finnish congenital nephrotic syndrome with captopril and indomethacin.
Topics: Captopril; Humans; Indomethacin; Infant, Newborn; Kidney; Kidney Failure, Chronic; Kidney Transplant | 1995 |
[Therapeutic bilateral renal artery embolization in the nephrotic syndrome].
Topics: Amyloidosis; Captopril; Cardiomyopathies; Contraindications; Creatinine; Crohn Disease; Drug Therapy | 1994 |
Use of NSAIDs in kidney transplantation.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclosporine; Follow-Up Studies; Graft Rejection; Graft Sur | 1993 |
Renal effects of captopril, indomethacin and nifedipine in nephrotic patients after an oral protein load.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflam | 1996 |
Nephrotic syndrome after norfloxacin.
Topics: Aged; Amlodipine; Anti-Infective Agents; Antihypertensive Agents; Clonidine; Creatinine; Diuretics; | 1996 |
Beneficial effect of ETA receptor blockade in a rat model of radiocontrast-induced nephropathy.
Topics: Acute Kidney Injury; Animals; Atrasentan; Contrast Media; Creatinine; Diatrizoate; Disease Models, A | 1997 |
Uncompensated polyuria in a mouse model of Bartter's syndrome.
Topics: Animals; Bartter Syndrome; Calcium; Carrier Proteins; Disease Models, Animal; Electrolytes; Hydronep | 2000 |
Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Diabetic Nephropa | 2000 |
Indomethacin protects permeability barrier from focal segmental glomerulosclerosis serum.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Albumins; Animals; Anti-Inflamma | 2002 |
Complement-independent nephrotoxic nephritis in the guinea pig.
Topics: Animals; Antibodies; Aprotinin; Azathioprine; Basement Membrane; Colchicine; Complement System Prote | 1977 |
[Long-term treatment of glomerulonephritis with indomethacin with special regard to quantity and selectivity of proteinuria].
Topics: Adolescent; Adult; Creatinine; Female; Glomerulonephritis; Humans; Immunodiffusion; Indomethacin; Ma | 1978 |
Single and multiple drug therapy in autologous immune complex nephritis in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Azathioprine; Basement Membrane; Compleme | 1976 |
Drug treatment of the chronic idiopathic glomerulopathies.
Topics: Adrenal Cortex Hormones; Alkylating Agents; B-Lymphocytes; Chronic Disease; Dipyridamole; Folic Acid | 1977 |
Some aspects of urinary kallikrein in a patient with Bartter's syndrome.
Topics: Aldosterone; Angiotensin II; Bartter Syndrome; Female; Humans; Hyperaldosteronism; Indomethacin; Iso | 1979 |
Effect of indomethacin on glomerular permeability in the nephrotic syndrome.
Topics: Adolescent; Adult; Aged; Creatinine; Female; Glomerular Filtration Rate; Glomerulonephritis; Humans; | 1979 |
Indomethacin in the treatment of idiopathic minimal lesion nephrotic syndrome.
Topics: Adolescent; Child; Child, Preschool; Humans; Indomethacin; Nephrotic Syndrome; Proteinuria | 1978 |
Focal glomerulosclerosis: natural history and treatment. A report of 70 cases.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Agents; Child; Female; Follow-Up St | 1978 |
[Monitoring of the clinical and morphological course of glomerulonephritis].
Topics: Adolescent; Adult; Azathioprine; Creatinine; Cyclophosphamide; Drug Therapy, Combination; Erythrocyt | 1978 |
Treatment of the nephrotic syndrome with indomethacin.
Topics: Angiotensin II; Diet, Sodium-Restricted; Glomerular Filtration Rate; Humans; Indomethacin; Kidney; N | 1978 |
Indomethacin and lysine acetylsalicylate in rats with autologous nephrotoxic serum nephritis. Biochemical and morphological studies.
Topics: Animals; Aspirin; Basement Membrane; Disease Models, Animal; Female; Glomerulonephritis; Immune Sera | 1978 |
Effect of indomethacin on the synthesis of glomerular basement membrane and on proteinuria in rats with nephrotoxic nephritis.
Topics: Animals; Basement Membrane; Indomethacin; Kidney Glomerulus; Male; Nephritis; Proline; Proteinuria; | 1977 |
[A patient with edemas].
Topics: Adult; Albumins; Edema; Female; Furosemide; Glomerular Filtration Rate; Humans; Indomethacin; Infusi | 1976 |
[Influence of indomethacin on the course of glomerulonephritis].
Topics: Adult; Angiotensin II; Chronic Disease; Female; Glomerulonephritis; Humans; Indomethacin; Proteinuri | 1976 |
Treatment of chronic glomerulonephritis with a combination of indomethacin and cyclophosphamide.
Topics: Creatinine; Cyclophosphamide; Drug Therapy, Combination; Glomerulonephritis; Humans; Indomethacin; P | 1975 |
[Treatment of kidney diseases with non-steroid anti-inflammatory drugs. I. Antiproteinuric effects of indomethacin].
Topics: Adolescent; Adult; Child; Female; Glomerulonephritis; Humans; Indomethacin; Male; Middle Aged; Prote | 1975 |
[Comparative study on the activity of various anti-inflammatory agents in chronically developing glomerulonephritis].
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Child; Child, Preschool; Chronic Disease; Dose-Response | 1975 |
The effect of indomethacin on proteinuria and kidney function in the nephrotic syndrome.
Topics: Adolescent; Adult; Depression, Chemical; Female; Follow-Up Studies; Glomerular Filtration Rate; Huma | 1976 |
Significance of urinary excretion of fibrin degradation products during treatment of glomerulonephritis.
Topics: Creatinine; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Fibrin Fibrin | 1976 |
Indomethacin attenuates exercise-induced proteinuria in hypertensive miniature swine.
Topics: Animals; Desoxycorticosterone; Dinoprostone; Female; Hemodynamics; Hypertension; Indomethacin; Physi | 1992 |
Exercise-induced proteinuria is attenuated by indomethacin.
Topics: Adult; Albuminuria; Aldosterone; Captopril; Exercise; Hemodynamics; Humans; Indomethacin; Male; Pros | 1992 |
Mechanism of the antiproteinuric effect of angiotensin-converting enzyme inhibition.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Enalapril; Female; Humans; Indomethacin; Lisinopril | 1990 |
Prostaglandins, angiotension II, and proteinuria.
Topics: Angiotensin II; Arachidonic Acid; Arachidonic Acids; Cyclooxygenase Inhibitors; Diet, Sodium-Restric | 1990 |
Impaired renal response to a meat meal in insulin-dependent diabetes: role of glucagon and prostaglandins.
Topics: Adult; Diabetes Mellitus, Type 1; Dietary Proteins; Eating; Female; Glucagon; Hemodynamics; Hormones | 1990 |
[Treatment of mercury-induced organ damage].
Topics: Acute Kidney Injury; Adult; Dimercaprol; Drug Therapy, Combination; Humans; Indomethacin; Kidney Fun | 1990 |
Nature of the glomerular capillary injury in human membranous glomerulopathy.
Topics: Dextrans; Glomerular Filtration Rate; Glomerulonephritis; Humans; Indomethacin; Kidney Function Test | 1986 |
Mechanism of the antiproteinuric effect of indomethacin in nephrotic humans.
Topics: Adolescent; Adult; Dextrans; Enzyme-Linked Immunosorbent Assay; Female; Glomerular Filtration Rate; | 1989 |
Effect of indomethacin on proteinuria in rats with autologous immune complex nephropathy.
Topics: Animals; Autoimmune Diseases; Glomerular Filtration Rate; Immune Complex Diseases; Indomethacin; Kid | 1985 |
Interactions of dimethyl sulfoxide and nonsteroidal anti-inflammatory agents in passive Heymann's nephritis.
Topics: Animals; Complement C3; Dimethyl Sulfoxide; Drug Therapy, Combination; Immune Complex Diseases; Indo | 1986 |
Indomethacin reduces proteinuria in passive Heymann nephritis in rats.
Topics: Animals; Dinoprostone; Glomerulonephritis; Imidazoles; Immune Complex Diseases; In Vitro Techniques; | 1987 |
A role for thromboxane in complement-mediated glomerular injury.
Topics: Animals; Cell Membrane Permeability; Complement Membrane Attack Complex; Complement System Proteins; | 1987 |
Effect of platelet-activating factor and its specific receptor antagonist on glomerular permeability to proteins in isolated perfused rat kidney.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Antioxidants; Basement Membra | 1988 |
Cyclosporine and other therapy-resistant nephrotic syndrome.
Topics: Adult; Cyclosporins; Drug Resistance; Humans; Indomethacin; Male; Nephrotic Syndrome; Proteinuria | 1988 |
Reduction of proteinuria by indomethacin in patients with nephrotic syndrome.
Topics: Dinoprostone; Glomerular Filtration Rate; Humans; Indomethacin; Nephrotic Syndrome; Prostaglandins E | 1986 |
Reduction of urinary protein and prostaglandin E2 excretion in the nephrotic syndrome by non-steroidal anti-inflammatory drugs.
Topics: Adult; Anti-Inflammatory Agents; Diclofenac; Dinoprostone; Flurbiprofen; Glomerular Filtration Rate; | 1986 |
Intravenously administered frusemide increases glomerular permeability.
Topics: Adolescent; Adult; Capillary Permeability; Drug Therapy, Combination; Furosemide; Glomerular Filtrat | 1987 |
Role of prostaglandins and angiotensin II in experimental glomerulonephritis.
Topics: Angiotensin II; Animals; Antibodies; Basement Membrane; Blood Pressure; Dinoprostone; Glomerulonephr | 1985 |
Antiproteinuric effect of indomethacin and dipyridamole in various glomerulopathies of adults.
Topics: Adolescent; Dipyridamole; Glomerulonephritis; Humans; Indomethacin; Proteinuria | 1985 |
[Course of nephropathy in systemic lupus erythematosus . Influence of the treatment on clinical symptoms, renal function and histology].
Topics: Adolescent; Adult; Aged; Antibodies, Antinuclear; Antimalarials; Azathioprine; Biopsy; Chlorambucil; | 1972 |
Pregnancy in a patient after cadaveric renal transplantation.
Topics: Adult; Agglutinins; Azathioprine; Biopsy; Blood Pressure; Cadaver; Estrogens; Female; Graft Rejectio | 1973 |
[Treatment of chronic glomerulopathy].
Topics: Anti-Inflammatory Agents; Azathioprine; Biopsy; Chlorambucil; Chronic Disease; Creatine; Cyclophosph | 1972 |
Ultrastructural changes of the glomeruli of the rat induced by indomethacin.
Topics: Animals; Cell Membrane Permeability; Creatinine; Cytoplasmic Granules; Endoplasmic Reticulum; Erythr | 1973 |
The use of indometacin for treating diffuse glomerulonephritis under experimental and clinical conditions.
Topics: Animals; Autoimmune Diseases; Blood Protein Disorders; Blood Proteins; Complement Fixation Tests; Dr | 1973 |
Urinary excretion of fibrinogen-fibrin-related antigen in glomerulonephritis: effect of indomethacin.
Topics: Adolescent; Adult; Aged; Antigens; Child; Chromatography, Gel; Creatinine; Female; Fibrin; Fibrinoge | 1973 |
Treatment of glomerulonephritis with indomethacin and heparin.
Topics: Adolescent; Adult; Aged; Child; Female; Glomerulonephritis; Heparin; Humans; Hypersensitivity; Indom | 1973 |
Indomethacin and platelet aggregation in chronic glomerulonephritis: existence of non-responders.
Topics: Adolescent; Adult; Antigens; Blood Coagulation; Blood Platelets; Chronic Disease; Creatinine; Female | 1974 |
[Indomethacin in the therapy of prolonged or chronic glomerulonephritis and of the nephrotic syndrome].
Topics: Adolescent; Adult; Biopsy; Child; Chronic Disease; Glomerulonephritis; Humans; Indomethacin; Kidney; | 1972 |
[Effect of indocide on the course of experimental glomerulonephritis].
Topics: Animals; Autoimmune Diseases; Blood Pressure; Blood Proteins; Complement Fixation Tests; Disease Mod | 1972 |
Pharmacological modification of urinary excretion of fibrinogen-like material in glomerulonephritis.
Topics: Adenosine Diphosphate; Collagen; Epinephrine; Fibrinogen; Glomerulonephritis; Hemagglutination Inhib | 1971 |
Indomethacin and urinary excretion of fibrinogen-like material in proliferative glomerulonephritis.
Topics: Agglutination Tests; Blood Platelets; Cell Aggregation; Chronic Disease; Fibrinogen; Glomerulonephri | 1970 |
[On the use of indomethacin in the treatment of renal diseases in childhood].
Topics: Blood Proteins; Child; Child, Preschool; Diuresis; Female; Glomerulonephritis; Humans; Indomethacin; | 1970 |
[Treatment of primary glomerulopathies with an anti-inflammatory substance: indomethacin].
Topics: Blood Sedimentation; Glomerulonephritis; Hematuria; Humans; Indomethacin; Proteinuria | 1971 |
[Indomethacin in nephropathies in children. Apropos of 21 cases].
Topics: Adolescent; Child; Child, Preschool; Glomerulonephritis; Humans; Indomethacin; Kidney Diseases; Prot | 1971 |
[Indomethacin in the treatment of the nephrotic syndrome and residuaproteinuria].
Topics: Humans; Indomethacin; Nephrotic Syndrome; Proteinuria | 1967 |
Etiology and treatment of gout--modern concepts.
Topics: Allopurinol; Colchicine; Crystallization; Diagnosis, Differential; Diet Therapy; Gout; Humans; Indom | 1968 |
Amyloidosis in childhood.
Topics: Adolescent; Amyloidosis; Arthritis, Juvenile; Female; Hematuria; Humans; Indomethacin; Kidney; Liver | 1969 |
[Therapeutic possibilities in chronic glomerulonephritis].
Topics: Adolescent; Adult; Azathioprine; Chlorambucil; Chronic Disease; Glomerulonephritis; Humans; Immunosu | 1969 |